{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:52:49Z","timestamp":1781610769614,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Porc Health Manag"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Diseases caused by\n                      <jats:italic>Streptococcus suis<\/jats:italic>\n                      (\n                      <jats:italic>S. suis<\/jats:italic>\n                      ) infection have a major impact on return on investment, use of antibiotics and animal welfare in piglet rearing worldwide.\n                      <jats:italic>S. suis<\/jats:italic>\n                      bacterins are commonly used as autogenous vaccines in different countries but experimental studies indicate limitations of bacterins in protective efficacy. In this study we read out levels of IgG, IgM and IgA binding to a\n                      <jats:italic>S. suis<\/jats:italic>\n                      serotype (\n                      <jats:italic>cps<\/jats:italic>\n                      ) 1 outbreak strain and bactericidal immunity after application of a homologous bacterin to sows and gilts. In the first trial we recorded immunogenicities after preparturient sow vaccination. In the second trial we compared an intranasal versus an intramuscular second boost application in gilts, and in the third trial the impact of the second boost application prior farrowing of gilts was specifically investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Preparturient intramuscular application of a\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 (\n                      <jats:italic>sly<\/jats:italic>\n                      <jats:sup>+<\/jats:sup>\n                      ,\n                      <jats:italic>mrp<\/jats:italic>\n                      <jats:sup>+<\/jats:sup>\n                      ,\n                      <jats:italic>epf<\/jats:italic>\n                      <jats:sup>+<\/jats:sup>\n                      ) autogenous bacterin elicited significantly increased levels of serum IgG but not IgM binding to the surface of the homologous strain. Accordingly, specific serum IgG levels were significantly increased in the second and fourth week of life in piglets of these sows. Increased IgG levels were associated with decreased proliferation of\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 in blood of 2-week-old piglets reared by vaccinated sows. The increase of IgM binding to\n                      <jats:italic>cps<\/jats:italic>\n                      1 between the fourth and sixth week of life was comparable between piglets farrowed by vaccinated and non-vaccinated sows. Levels of serum IgA binding to\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 were not different between piglets fostered by vaccinated and non-vaccinated sows. Between the fourth and sixth week of life we recorded a significant increase in specific serum IgA levels. Intramuscular prime boost vaccination of gilts during quarantine elicited significantly increased specific serum IgG but not IgA levels. Levels of IgG in colostrum binding to\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 were significantly increased only in gilts boostered intramuscularly 3 weeks pre farrowing and not in gilts boostered intranasally. Neither intramuscular nor intranasal boostering was associated with increased levels of specific IgA in colostrum. The significant influence of the second intramuscular boost vaccination pre farrowing in gilts on IgG levels in colostrum and in blood of 2-week-old-piglets was confirmed in the last trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Intramuscular prime-boost vaccination of sows and gilts with an autogenous\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 bacterin is associated with significantly increased levels of specific IgG in their colostrum and serum of 2- and 4-week-old piglets based on the investigations in one herd that had experienced a severe\n                      <jats:italic>S. suis cps<\/jats:italic>\n                      1 outbreak. After prime-boost vaccination during quarantine gilts should be boostered again pre-farrowing to ensure increased IgG levels in their piglets. A way to elicit increased specific IgA levels in colostrum, milk or serum through intramuscular or intranasal bacterin application was not identified.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40813-025-00453-6","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:44:19Z","timestamp":1752853459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autogenous Streptococcus suis serotype 1 bacterin: immunogenicities of sow and gilt vaccination protocols"],"prefix":"10.1186","volume":"11","author":[{"given":"Georg","family":"Freym\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Unterweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Voglmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph G.","family":"Baums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"2","key":"453_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/fmb.11.149","volume":"7","author":"N Fittipaldi","year":"2012","unstructured":"Fittipaldi N, Segura M, Grenier D, Gottschalk M. Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol. 2012;7(2):259\u201379. https:\/\/doi.org\/10.2217\/fmb.11.149.","journal-title":"Future Microbiol"},{"issue":"1","key":"453_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S146625230999003X","volume":"10","author":"CG Baums","year":"2009","unstructured":"Baums CG, Valentin-Weigand P. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim Health Res Reviews. 2009;10(1):65\u201383. https:\/\/doi.org\/10.1017\/S146625230999003X.","journal-title":"Anim Health Res Reviews"},{"key":"453_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fmicb.2018.00480","volume":"9","author":"D V\u00f6tsch","year":"2018","unstructured":"V\u00f6tsch D, Willenborg M, Weldearegay YB, Valentin-Weigand P. Streptococcus suis - The two faces of a pathobiont in the porcine respiratory tract. Front Microbiol. 2018;9:480. https:\/\/doi.org\/10.3389\/fmicb.2018.00480","journal-title":"Front Microbiol"},{"key":"453_CR4","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1038\/emi.2014.45","volume":"3","author":"G Goyette-Desjardins","year":"2014","unstructured":"Goyette-Desjardins G, Auger J-PP, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. 2014;3:e45.","journal-title":"Emerg Microbes Infect"},{"key":"453_CR5","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1128\/JCM.40.10.3671-3680.2002","volume":"40","author":"SJ King","year":"2002","unstructured":"King SJ, Leigh JA, Heath PJ, Luque I, Tarradas C, Dowson CG, et al. Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J Clin Microbiol. 2002;40:3671\u201380.","journal-title":"J Clin Microbiol"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40813-020-00150-6","volume":"6","author":"K Rieckmann","year":"2020","unstructured":"Rieckmann K, Pendzialek SM, Vahlenkamp T, Baums CG. A critical review speculating on the protective efficacies of autogenous Streptococcus suis bacterins as used in Europe. Porcine Health Manag. 2020;6:12. https:\/\/doi.org\/10.1186\/s40813-020-00150-6. eCollection.","journal-title":"Porcine Health Manag"},{"key":"453_CR7","doi-asserted-by":"publisher","unstructured":"Obradovic MR, Corsaut L, Dolbec D, Gottschalk M, Segura M. Experimental evaluation of protection and immunogenicity of Streptococcus suis bacterin based vaccines formulated with different commercial adjuvants in weaned piglets. Vet Res [Internet]. 2021;1\u201316. Available from: https:\/\/doi.org\/10.1186\/s13567-021-01004-x","DOI":"10.1186\/s13567-021-01004-x"},{"key":"453_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1128\/CVI.00371-08","volume":"16","author":"CG Baums","year":"2009","unstructured":"Baums CG, Kock C, Beineke A, Bennecke K, Goethe R, Schr\u00f6der C, et al. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin Vaccine Immunol. 2009;16:200\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"453_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/vr.148.15.473","volume":"148","author":"HJ Wisselink","year":"2001","unstructured":"Wisselink HJ, Vecht U, Stockhofe-Zurwieden N, Smith HE. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet Rec. 2001;148:473\u20137.","journal-title":"Vet Rec"},{"issue":"19","key":"453_CR10","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.vaccine.2015.03.047","volume":"33","author":"J Seele","year":"2015","unstructured":"Seele J, Hillermann L-MM, Beineke A, Seitz M, von Pawel-Rammingen U, Valentin-Weigand P, et al. The Immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2. Vaccine. 2015;33(19):2207\u201312. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.047","journal-title":"Vaccine"},{"key":"453_CR11","doi-asserted-by":"crossref","unstructured":"Baums CG, Br\u00fcggemann C, Kock C, Beineke A, Waldmann K-H, Valentin-Weigand P. Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaning. Clin Vaccine Immunol. 2010;17:1589\u201397.","DOI":"10.1128\/CVI.00159-10"},{"key":"453_CR12","doi-asserted-by":"crossref","unstructured":"B\u00fcttner N, Beineke A, de Buhr N, Lilienthal S, Merkel J, Waldmann K-H et al. Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy. Vet Immunol Immunopathol. 2012;146:191\u2013200.","DOI":"10.1016\/j.vetimm.2012.03.012"},{"key":"453_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.vaccine.2011.12.035","volume":"30","author":"CNTT Dekker","year":"2012","unstructured":"Dekker CNTT, Bouma A, Daemen AJJMJM, van Leengoed LAMGMG, Jonker FH, Wagenaar JA, et al. Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization. Vaccine. 2012;30:1379\u201387.","journal-title":"Vaccine"},{"issue":"12","key":"453_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1586\/14760584.2015.1101349","volume":"14","author":"M Segura","year":"2015","unstructured":"Segura M. Streptococcus suis vaccines: candidate antigens and progress. Expert Rev Vaccines. 2015;14(12):1587\u2013608. https:\/\/doi.org\/10.1586\/14760584.2015.1101349.","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"453_CR15","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/infdis\/jiz352","volume":"220","author":"B Wang","year":"2019","unstructured":"Wang B, Xing X, Bi S, Fan X, Jin M, Liu W, et al. Intranasal vaccination with multiple virulence factors promotes mucosal clearance of Streptococcus suis across serotypes and protects against meningitis in mice. J Infect Dis. 2019;220(10):1679\u201387. https:\/\/doi.org\/10.1093\/infdis\/jiz352.","journal-title":"J Infect Dis"},{"issue":"3","key":"453_CR16","doi-asserted-by":"publisher","first-page":"e00559","DOI":"10.1128\/IAI.00559-17","volume":"86","author":"SL Brockmeier","year":"2018","unstructured":"Brockmeier SL, Loving CL, Nicholson TL, Wang J, Peters SE, Weinert L, et al. Use of proteins identified through a functional genomic screen to develop a protein subunit vaccine that provides significant protection against virulent Streptococcus suis in pigs. Infect Immun. 2018;86(3):e00559\u201317. https:\/\/doi.org\/10.1128\/IAI.00559-17.","journal-title":"Infect Immun"},{"key":"453_CR17","doi-asserted-by":"publisher","unstructured":"Mayer L, Bornemann N, Lehnert S, Greeff A, De, Strutzberg-minder K, Rieckmann K et al. Survival patterns of Streptococcus suis serotypes 1 and 14 in porcine blood indicate cross-reactive bactericidal antibodies in naturally infected pigs. Vet Microbiol [Internet]. 2021;260:109183. Available from: https:\/\/doi.org\/10.1016\/j.vetmic.2021.109183","DOI":"10.1016\/j.vetmic.2021.109183"},{"issue":"5","key":"453_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1128\/JB.01875-12","volume":"195","author":"J Seele","year":"2013","unstructured":"Seele J, Singpiel A, Spoerry C, Pawel-Rammingen U, Von, Valentin-Weigand P, Baums CG. Identification of a novel host-specific IgM protease in Streptococcus suis. J Bacteriol. 2013;195(5):930\u201340. https:\/\/doi.org\/10.1128\/JB.01875-12.","journal-title":"J Bacteriol"},{"key":"453_CR19","doi-asserted-by":"crossref","unstructured":"Smith HE, Rijnsburger M, Stockhofe-Zurwieden N, Wisselink HJ, Vecht U, Smits MA. Virulent strains of Streptococcus suis serotype 2 and highly virulent strains of Streptococcus suis serotype 1 can be recognized by a unique ribotype profile. J Clin Microbiol. 1997;35:1049\u20131053.","DOI":"10.1128\/jcm.35.5.1049-1053.1997"},{"key":"453_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0378-1135(00)00188-7","volume":"74","author":"HJ Wisselink","year":"2000","unstructured":"Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, Peperkamp K, Vecht U. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol. 2000;74:237\u201348.","journal-title":"Vet Microbiol"},{"issue":"1","key":"453_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13567-024-01313-x","volume":"55","author":"A Jeffery","year":"2024","unstructured":"Jeffery A, Gilbert M, Corsaut L, Gaudreau A, Obradovic MR, Cloutier S, et al. Immune response induced by a Streptococcus suis multi-serotype autogenous vaccine used in sows to protect post-weaned piglets. Vet Res. 2024;55(1):57. https:\/\/doi.org\/10.1186\/s13567-024-01313-x.","journal-title":"Vet Res"},{"key":"453_CR22","doi-asserted-by":"crossref","unstructured":"Corsaut L, Martelet L, Goyette-Desjardins G, Beauchamp G, Denicourt M, Gottschalk M et al. Immunogenicity study of a Streptococcus suis autogenous vaccine in preparturient sows and evaluation of passive maternal immunity in piglets. BMC Vet Res. 2021;17:72.","DOI":"10.1186\/s12917-021-02774-4"},{"key":"453_CR23","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1016\/j.vaccine.2020.08.054","volume":"38","author":"W Charerntantanakul","year":"2020","unstructured":"Charerntantanakul W. Adjuvants for swine vaccines: mechanisms of actions and adjuvant effects. Vaccine. 2020;38:6659\u201381.","journal-title":"Vaccine"},{"issue":"3","key":"453_CR24","doi-asserted-by":"publisher","first-page":"e00598","DOI":"10.1128\/IAI.00598-19","volume":"88","author":"V Rungelrath","year":"2019","unstructured":"Rungelrath V, \u00d6hlmann S, Alber G, Schr\u00f6dl W, von K\u00f6ckritz-Blickwede M, de Buhr N, et al. Survival of Streptococcus suis in Porcine blood is limited by the antibody- and complement- dependent oxidative burst response of granulocytes. Infect Immun. 2019;88(3):e00598\u201319. https:\/\/doi.org\/10.1128\/IAI.00598-19.","journal-title":"Infect Immun"},{"issue":"1","key":"453_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s1074-7613(02)00341-2","volume":"17","author":"A Phalipon","year":"2002","unstructured":"Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corth\u00e9sy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity. 2002;17(1):107\u201315. https:\/\/doi.org\/10.1016\/s1074-7613(02)00341-2.","journal-title":"Immunity"},{"key":"453_CR26","doi-asserted-by":"publisher","unstructured":"Binsker U, Lees JA, Hammond AJ, Weiser JN. Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1. J Clin Invest 130(2):927\u201341. https:\/\/doi.org\/10.1172\/JCI132005","DOI":"10.1172\/JCI132005"},{"key":"453_CR27","doi-asserted-by":"publisher","unstructured":"Rieckmann K, Seydel A, Szewczyk K, Klimke K, Rungelrath V, Baums CG. Streptococcus suis cps7: an emerging virulent sequence type (ST29) shows a distinct, IgM-determined pattern of bacterial survival in blood of piglets during the early adaptive immune response after weaning. Vet Res. 2018;49(1). https:\/\/doi.org\/10.1186\/s13567-018-0544-8.","DOI":"10.1186\/s13567-018-0544-8"},{"key":"453_CR28","doi-asserted-by":"publisher","first-page":"100590","DOI":"10.1016\/j.jvacx.2024.100590","volume":"21","author":"L Mayer","year":"2024","unstructured":"Mayer L, Liedel C, Klose K, de Greeff A, Rieckmann K, Baums CG. Immunogenicities of vaccines including the Immunoglobulin M-degrading enzyme of Streptococcus suis, rIde Ssuis, and protective efficacy against serotype 14 in piglets. Vaccine X. 2024;21:100590. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100590","journal-title":"Vaccine X"}],"container-title":["Porcine Health Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40813-025-00453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40813-025-00453-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40813-025-00453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:09:29Z","timestamp":1781608169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40813-025-00453-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1186\/s40813-025-00453-6","relation":{},"ISSN":["2055-5660"],"issn-type":[{"value":"2055-5660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The vaccination protocols and collection of samples in trials 1 and 3 were part of regular health managements in this farm and were performed by the veterinarian in charge. Accordingly, an official approval for the application of the autogenous vaccine was not necessary. Trial 2 was approved by the Ethics and Animal Welfare Committee of the University of Veterinary Medicine, Vienna in accordance with the University\u2019s guidelines for Good Scientific Practice and authorized by the Austrian Federal Ministry of Education, Science and Research (ref BMBWF 2022\u2009\u2212\u20090.474.437) in accordance with current legislation. Collection of blood from non-infected piglets for scientific purposes such as the reconstituted bactericidal assay in this study is registered under the permit number A09\/19 for members of the Institute of Bacteriology and Mycology in Saxony, Germany. 14 challenge experiment in Saxony, Germany [\n                      \n                      ]. Piglets in this challenge experiment were infected experimentally and cared for in accordance with the principles outlined in the EU Directive 2010\/63\/EU and the German Animal Protection Law (Tierschutzgesetz). The challenge experiment of this study was approved by the Saxony Regional Office (permit no. TVV37\/17) which includes review and approval by an ethics committee. All animal experiments or samplings were in accordance with the principles outlined in the European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}